SEATTLE, Aug. 27, 2015 /PRNewswire/ -- ActX was named Allscripts App of the Month for June 2015 for providing real-time genomic decision support to physicians using Allscripts ambulatory EHRs. ActX's certified integration with Allscripts through the award-winning Allscripts Developer Program makes genomics practical for Allscripts clients by automatically checking medications for drug-genomic interactions and providing alerts for actionable genomic patient risks.
"We're honored to have been chosen as Allscripts App of the Month," says Dr. Andrew Ury, ActX CEO. "Our partnership with the Allscripts Developer Program helps us introduce ActX to Allscripts practices around the country."
The ActX – Allscripts integrated solution is available today, and delivers the actionable, evidence-based information physicians need, in a way they can trust. The ActX Service is designed to integrate seamlessly into the current workflow of busy Allscripts practices through:
- Automatic drug genomic interaction alerts for all prescriptions
- Alerts for serious genomic risks
- Patient Genomic Profile integrated into Allscripts
- Easy patient authorization for the ActX Service
- Affordable patient DNA testing
By including patient genetic testing and secure genomic decision directly in the Allscripts EHR, ActX is a turnkey genomic solution, from sample to analysis. "The App of the Month program is intended to highlight some of Allscripts most innovative applications," says Stanley Crane, Chief Innovation Officer at Allscripts. "It is exciting that Allscripts can now offer its clients sophisticated precision medicine capabilities through our partnership with ActX."
For more information about the certified solution, visit ActX on the Allscripts Application Store.
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient's genetic information to guide therapy. Integrated into a physician's normal software tools (the electronic medical record) and workflow, ActX analyzes the patient's genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks. For more information about ActX and taking the next step towards precision medicine, visit us at www.actx.com, contact us at email@example.com or call 888-998-2289.
SOURCE ActX, Inc.